LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
about
Multitargeted bioactive ligands for PPARs discovered in the last decade.Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome.PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.Review. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease.FGF21-induced by carbon monoxide mediates metabolic homeostasis via the PERK/ATF4 pathway.
P2860
LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties.
@en
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties.
@nl
type
label
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties.
@en
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties.
@nl
prefLabel
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties.
@en
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties.
@nl
P2093
P2860
P50
P356
P1476
LT175 is a novel PPARα/γ ligan ...... reduced adipogenic properties
@en
P2093
Donatella Caruso
Fulvio Loiodice
Gaia Cermenati
Gianpaolo Rando
Giorgio Pochetti
Krister Bamberg
Marco Giudici
Omar Maschi
Uliano Guerrini
P2860
P304
P356
10.1074/JBC.M113.506394
P407
P50
P577
2014-01-22T00:00:00Z